Cargando…

SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism

The prevalence of insulin resistance and type 2 diabetes (T2DM) in children is increasing, and identifying where prevention can best be implemented is an emerging area of research. The association of low birth weight with long-term risk for poor metabolic health is well established, but the associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Monica, Kuang, Alan, Josefson, Jami, Lowe, Lynn, Metzger, Boyd, Scholtens, Denise, Lowe, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552197/
http://dx.doi.org/10.1210/js.2019-SAT-124
_version_ 1783424547111829504
author Bianco, Monica
Kuang, Alan
Josefson, Jami
Lowe, Lynn
Metzger, Boyd
Scholtens, Denise
Lowe, William
author_facet Bianco, Monica
Kuang, Alan
Josefson, Jami
Lowe, Lynn
Metzger, Boyd
Scholtens, Denise
Lowe, William
author_sort Bianco, Monica
collection PubMed
description The prevalence of insulin resistance and type 2 diabetes (T2DM) in children is increasing, and identifying where prevention can best be implemented is an emerging area of research. The association of low birth weight with long-term risk for poor metabolic health is well established, but the association of newborn size at birth, including adiposity, with measures of glucose metabolism in children has not been fully elucidated. To address this, we used longitudinal data from the international, multi-ethnic Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and HAPO Follow Up Study (FUS). Newborn birth weight (BW) and sum of skinfolds (SSF), as a measure of adiposity, collected during HAPO, together with glucose and C-peptide levels collected during an oral glucose tolerance test (OGTT) in 4160 HAPO FUS offspring at age 10-14 years were examined. Multiple logistic and linear regression were used for statistical analyses to examine associations between primary predictors, BW and SSF, with child metabolic outcomes. Covariate adjustments included HAPO field center, child age, sex, Tanner stage, maternal variables at pregnancy OGTT (age, height, mean arterial pressure, parity (0, 1+), smoking (yes/no), drinking alcohol (yes/no), gestational age), child’s family history of diabetes in first degree relatives and child’s BMI z-score. BW was inversely associated with the 30-min, 1-h, and 2-h plasma glucose levels (Beta=-1.59, CI: -2.53 - -0.65, p<0.0001, Beta=-2.09, CI: -3.30 - -0.88, p=0.007, and Beta=-1.47, CI: -2.28- -0.65, p=0.0004, respectively for BW higher by 1 standard deviation), as was SSF (Beta= -1.40, CI: -2.19 - -0.60, p< 0.0001, Beta=-1.97, CI: -3.00 - -0.94, p=0.0002, and Beta=-0.98, CI: -1.67 - -0.28, p=0.01 respectively for SSF higher by 1 standard deviation). BW and SSF were also associated with a higher Matsuda index, a measure of insulin sensitivity (Beta=1.77, CI: 1.32-2.21, p<0.0001 and Beta=0.89, CI: 0.50-1.27 p<0.0001, respectively). However, only SSF had a positive association with the disposition index, a measure of beta cell compensation for insulin resistance (Beta=0.03, CI: 0.01-0.05, p=0.01). No association was found between BW and SSF and impaired glucose tolerance, while a modest decrease in risk for impaired fasting glucose was seen with higher BW and SSF (OR=-0.83, CI: 0.70-0.98, p=0.03 and OR=0.85, CI: 0.74-0.97, p=0.02, respectively). This study demonstrates that higher BW and newborn adiposity are associated with lower glucose levels and higher insulin sensitivity in childhood. This suggests a complex relationship between birth size and long-term metabolic health in which, after adjusting for child BMI, higher BW and adiposity are associated with better metabolic health during childhood.
format Online
Article
Text
id pubmed-6552197
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65521972019-06-13 SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism Bianco, Monica Kuang, Alan Josefson, Jami Lowe, Lynn Metzger, Boyd Scholtens, Denise Lowe, William J Endocr Soc Diabetes Mellitus and Glucose Metabolism The prevalence of insulin resistance and type 2 diabetes (T2DM) in children is increasing, and identifying where prevention can best be implemented is an emerging area of research. The association of low birth weight with long-term risk for poor metabolic health is well established, but the association of newborn size at birth, including adiposity, with measures of glucose metabolism in children has not been fully elucidated. To address this, we used longitudinal data from the international, multi-ethnic Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and HAPO Follow Up Study (FUS). Newborn birth weight (BW) and sum of skinfolds (SSF), as a measure of adiposity, collected during HAPO, together with glucose and C-peptide levels collected during an oral glucose tolerance test (OGTT) in 4160 HAPO FUS offspring at age 10-14 years were examined. Multiple logistic and linear regression were used for statistical analyses to examine associations between primary predictors, BW and SSF, with child metabolic outcomes. Covariate adjustments included HAPO field center, child age, sex, Tanner stage, maternal variables at pregnancy OGTT (age, height, mean arterial pressure, parity (0, 1+), smoking (yes/no), drinking alcohol (yes/no), gestational age), child’s family history of diabetes in first degree relatives and child’s BMI z-score. BW was inversely associated with the 30-min, 1-h, and 2-h plasma glucose levels (Beta=-1.59, CI: -2.53 - -0.65, p<0.0001, Beta=-2.09, CI: -3.30 - -0.88, p=0.007, and Beta=-1.47, CI: -2.28- -0.65, p=0.0004, respectively for BW higher by 1 standard deviation), as was SSF (Beta= -1.40, CI: -2.19 - -0.60, p< 0.0001, Beta=-1.97, CI: -3.00 - -0.94, p=0.0002, and Beta=-0.98, CI: -1.67 - -0.28, p=0.01 respectively for SSF higher by 1 standard deviation). BW and SSF were also associated with a higher Matsuda index, a measure of insulin sensitivity (Beta=1.77, CI: 1.32-2.21, p<0.0001 and Beta=0.89, CI: 0.50-1.27 p<0.0001, respectively). However, only SSF had a positive association with the disposition index, a measure of beta cell compensation for insulin resistance (Beta=0.03, CI: 0.01-0.05, p=0.01). No association was found between BW and SSF and impaired glucose tolerance, while a modest decrease in risk for impaired fasting glucose was seen with higher BW and SSF (OR=-0.83, CI: 0.70-0.98, p=0.03 and OR=0.85, CI: 0.74-0.97, p=0.02, respectively). This study demonstrates that higher BW and newborn adiposity are associated with lower glucose levels and higher insulin sensitivity in childhood. This suggests a complex relationship between birth size and long-term metabolic health in which, after adjusting for child BMI, higher BW and adiposity are associated with better metabolic health during childhood. Endocrine Society 2019-04-30 /pmc/articles/PMC6552197/ http://dx.doi.org/10.1210/js.2019-SAT-124 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Diabetes Mellitus and Glucose Metabolism
Bianco, Monica
Kuang, Alan
Josefson, Jami
Lowe, Lynn
Metzger, Boyd
Scholtens, Denise
Lowe, William
SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
title SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
title_full SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
title_fullStr SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
title_full_unstemmed SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
title_short SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
title_sort sat-124 hyperglycemia and adverse pregnancy outcome follow-up study (hapo fus): newborn anthropometrics and childhood glucose metabolism
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552197/
http://dx.doi.org/10.1210/js.2019-SAT-124
work_keys_str_mv AT biancomonica sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism
AT kuangalan sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism
AT josefsonjami sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism
AT lowelynn sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism
AT metzgerboyd sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism
AT scholtensdenise sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism
AT lowewilliam sat124hyperglycemiaandadversepregnancyoutcomefollowupstudyhapofusnewbornanthropometricsandchildhoodglucosemetabolism